# Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

> **NCT06240767** · PHASE1 · UNKNOWN · sponsor: **Wuxi People's Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Solid Tumor, Adult
- Advanced Cancer

## Interventions

- **BIOLOGICAL:** Granulocyte infusion

## Key facts

- **NCT ID:** NCT06240767
- **Lead sponsor:** Wuxi People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06240767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06240767, "Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06240767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*